| Organo-tin antitumor compounds: Their present status in drug development and future perspectives F Arjmand, S Parveen, S Tabassum, C Pettinari Inorganica Chimica Acta 423, 26-37, 2014 | 124 | 2014 |
| Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action S Parveen, F Arjmand, S Tabassum European Journal of Medicinal Chemistry 175, 269-286, 2019 | 60 | 2019 |
| Metal complexes of NSAIDs as potent anti-tumor chemotherapeutics: Mechanistic insights into cytotoxic activity via multiple pathways primarily by inhibition of COX–1 and COX–2 … HY Khan, S Parveen, I Yousuf, S Tabassum, F Arjmand Coordination Chemistry Reviews 453, 214316, 2022 | 30 | 2022 |
| Recent advances in metallodrug-like molecules targeting non-codingRNAs in cancer chemotherapy FA Zeenat Afsan, Surbhi Sharma, Sabiha Parveen, Imtiyaz Yousuf, Sara Sartaj ... Coordination Chemistry Reviews 387, 47-59, 2019 | 30 | 2019 |
| Synthesis of chiral R/S-pseudopeptide-based Cu (II) & Zn (II) complexes for use in targeted delivery for antitumor therapy: enantiomeric discrimination with CT-DNA and pBR322 … S Parveen, S Tabassum, F Arjmand RSC advances 7 (11), 6587-6597, 2017 | 29 | 2017 |
| Copper (II) L/D-valine-(1, 10-phen) complexes target human telomeric G-quadruplex motifs and promote site-specific DNA cleavage and cellular cytotoxicity F Arjmand, S Sharma, S Parveen, L Toupet, Z Yu, JA Cowan Dalton Transactions 49 (28), 9888-9899, 2020 | 23 | 2020 |
| Synthesis and characterization of Co (II) and Fe (II) peptide conjugates as hydrolytic cleaving agents and their preferential enantiomeric disposition for CT-DNA: structural … S Parveen, M Usman, S Tabassum, F Arjmand RSC advances 5 (88), 72121-72131, 2015 | 20 | 2015 |
| Human topoisomerase I mediated cytotoxicity profile of l-valine-quercetin diorganotin (IV) antitumor drug entities S Parveen, S Tabassum, F Arjmand Journal of Organometallic Chemistry 823, 23-33, 2016 | 19 | 2016 |
| Enantiomeric copper based anticancer agents promoting sequence-selective cleavage of G-quadruplex telomeric DNA and non-random cleavage of plasmid DNA S Parveen, JA Cowan, Z Yu, F Arjmand Metallomics 12 (6), 988-999, 2020 | 17 | 2020 |
| New Ionic Cu(II) and Co(II) DACH–Flufenamate Conjugate Complexes: Spectroscopic Characterization, Single X–Ray Studies and Cytotoxic Activity on Human Cancer Cell Lines FA Huzaifa Yasir Khan, Siffeen Zehra,Sabiha Parveen,Imtiyaz Yousuf, Sartaj ... ChemistrySelect 3, 12764– 12772, 2018 | 13 | 2018 |
| RNA-targeted Cu (II)-based potential antitumor drug entity: Comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies S Parveen, K Fatima, S Zehra, F Arjmand Journal of Biomolecular Structure and Dynamics 39 (16), 6070-6083, 2021 | 12 | 2021 |
| Elucidating the interaction of enantiomeric Cu (II) complexes with DNA, RNA and HSA: A comparative study S Parveen, S Jafri, HY Khan, S Tabassum, F Arjmand Polyhedron 210, 115501, 2021 | 8 | 2021 |
| Protective effects of a polyherbal medicine, Majoon Suranjan against bisphenol-A induced genetic, oxidative and tissue damages D Singh, MA Khan, K Akhtar, S Rehman, S Parveen, KMY Amin, ... Drug and Chemical Toxicology 46 (6), 1057-1069, 2023 | 4 | 2023 |
| Molecular interaction of lysozyme with therapeutic drug azithromycin: Effect of sodium dodecyl sulfate on binding profile S Parveen, MS Ali, HA Al-Lohedan, N Hoti, S Tabassum International Journal of Biological Macromolecules 242, 124844, 2023 | 2 | 2023 |
| α-Synuclein seeding activity in duodenum biopsies from Parkinson’s disease patients S Vascellari, CD Orrù, BR Groveman, S Parveen, G Fenu, G Pisano, ... Plos Pathogens 19 (6), e1011456, 2023 | 2 | 2023 |
| Interaction of Carrier Protein with Potential Metallic Drug Candidate N-Glycoside ‘GATPT’: Validation by Multi-Spectroscopic and Molecular Docking Approaches ST Sabiha Parveen, Mohd. Sajid Ali, Hamad A. Al-Lohedan Molecules 26, 6641., 2021 | 1 | 2021 |
| Chiral discrimination of metal–based chemotherapeutics Co(II), Cu(II) and Zn(II) towards the ultimate drug target–DNA MA Farukh Arjmand, Shazia Parveen, Sabiha Parveen Chemistry & Biology Interface 3 (3), 137-145, 2013 | | 2013 |
Prof. Sartaj TabassumDepartment of Chemistry,Aligarh Muslim UniversityVerified email at amu.ac.in
